A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients

ObjectiveWhole lung irradiation (WLI) plays a crucial role in local control in pediatric patients with lung metastases and improves patient survival. The intention of this research was to explore the advantage of cardiac sparing between photons and protons during WLI. We also propose a new solution...

Full description

Bibliographic Details
Main Authors: Xue Sha, Jinghao Duan, Xiutong Lin, Jian Zhu, Ruohui Zhang, Tao Sun, Hui Wang, Xiangjuan Meng, Yong Yin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.611514/full
_version_ 1818447559857799168
author Xue Sha
Jinghao Duan
Xiutong Lin
Jian Zhu
Jian Zhu
Ruohui Zhang
Tao Sun
Hui Wang
Xiangjuan Meng
Yong Yin
author_facet Xue Sha
Jinghao Duan
Xiutong Lin
Jian Zhu
Jian Zhu
Ruohui Zhang
Tao Sun
Hui Wang
Xiangjuan Meng
Yong Yin
author_sort Xue Sha
collection DOAJ
description ObjectiveWhole lung irradiation (WLI) plays a crucial role in local control in pediatric patients with lung metastases and improves patient survival. The intention of this research was to explore the advantage of cardiac sparing between photons and protons during WLI. We also propose a new solution for cardiac sparing with proton techniques.MethodsEleven patients with pediatric tumors and pulmonary metastasis treated with 12 Gy WLI (all received volumetric-modulated arc therapy (VMAT)) in our institute between 2010 and 2019 were retrospectively selected. Each patient was replanned with intensity-modulated radiation therapy (IMRT), helical tomotherapy (HT), and two intensity-modulated proton radiotherapy (IMPT) plans (IMPT-1 and IMPT-2). IMPT-1 considered the whole lung as the planning target volume (PTV), utilizing the anteroposterior technique (0/180°). IMPT-2 was a new proton solution that we proposed in this research. This approach considered the unilateral lung as the PTV, and 3 ipsilateral fields were designed for each lung. Then, IMPT-2 was generated by summing two unilateral lung plans. The primary objective was to obtain adequate coverage (95% of the prescription dose to the PTV) while maximally sparing the dose to the heart. The PTV coverage, conformity index (CI), homogeneity index (HI), and dose–volume statistics of the heart and substructures were assessed by means of the averages of each comparison parameter.ResultsAll treatment techniques achieved the target volume coverage required by clinical practice. HT yielded the best coverage and homogeneity for the target structure compared with other techniques. The CI from IMRT was excellent. For photon radiation therapy, the HT plan afforded superior dose sparing for the V5, V6, V7, V8, and Dmean of the heart and Dmean of the right ventricle (RV). IMRT displayed the most notable dose reductions in the V9, V10, V11, and V12 of the heart and Dmean of the right atrium (RA). The VMAT plan was the least effective on the heart and substructures. However, compared with photon radiation therapy, IMPT-1 did not show an advantage for heart protection. Interestingly, IMPT-2 provided significant superiority in cardiac sparing, including maximum dose sparing for the V5, V6, V7, V8, V9 and Dmean of the heart and Dmean of the RA, RV, left atrium (LA) and left ventricle (LV) compared to all other techniques.ConclusionsConsidering the complex anatomical relation between target volumes and organs at risk (OARs), IMPT can provide a dose advantage for organs located outside of the target area rather than within or surrounding the area. It is hoped that advances in proton therapy (PT) plan design will lead to further improvements in radiotherapy approaches and provide the best treatment choice for individual patients.
first_indexed 2024-12-14T20:05:33Z
format Article
id doaj.art-50614ece8bbf4e2ebd7fb54e7d3747fe
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-14T20:05:33Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-50614ece8bbf4e2ebd7fb54e7d3747fe2022-12-21T22:49:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.611514611514A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor PatientsXue Sha0Jinghao Duan1Xiutong Lin2Jian Zhu3Jian Zhu4Ruohui Zhang5Tao Sun6Hui Wang7Xiangjuan Meng8Yong Yin9Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaShandong Provincial Key Laboratory of Digital Medicine and Computer-Assisted Surgery, Qingdao, ChinaDepartment of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Qingdao Central Hospital, Qingdao, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaObjectiveWhole lung irradiation (WLI) plays a crucial role in local control in pediatric patients with lung metastases and improves patient survival. The intention of this research was to explore the advantage of cardiac sparing between photons and protons during WLI. We also propose a new solution for cardiac sparing with proton techniques.MethodsEleven patients with pediatric tumors and pulmonary metastasis treated with 12 Gy WLI (all received volumetric-modulated arc therapy (VMAT)) in our institute between 2010 and 2019 were retrospectively selected. Each patient was replanned with intensity-modulated radiation therapy (IMRT), helical tomotherapy (HT), and two intensity-modulated proton radiotherapy (IMPT) plans (IMPT-1 and IMPT-2). IMPT-1 considered the whole lung as the planning target volume (PTV), utilizing the anteroposterior technique (0/180°). IMPT-2 was a new proton solution that we proposed in this research. This approach considered the unilateral lung as the PTV, and 3 ipsilateral fields were designed for each lung. Then, IMPT-2 was generated by summing two unilateral lung plans. The primary objective was to obtain adequate coverage (95% of the prescription dose to the PTV) while maximally sparing the dose to the heart. The PTV coverage, conformity index (CI), homogeneity index (HI), and dose–volume statistics of the heart and substructures were assessed by means of the averages of each comparison parameter.ResultsAll treatment techniques achieved the target volume coverage required by clinical practice. HT yielded the best coverage and homogeneity for the target structure compared with other techniques. The CI from IMRT was excellent. For photon radiation therapy, the HT plan afforded superior dose sparing for the V5, V6, V7, V8, and Dmean of the heart and Dmean of the right ventricle (RV). IMRT displayed the most notable dose reductions in the V9, V10, V11, and V12 of the heart and Dmean of the right atrium (RA). The VMAT plan was the least effective on the heart and substructures. However, compared with photon radiation therapy, IMPT-1 did not show an advantage for heart protection. Interestingly, IMPT-2 provided significant superiority in cardiac sparing, including maximum dose sparing for the V5, V6, V7, V8, V9 and Dmean of the heart and Dmean of the RA, RV, left atrium (LA) and left ventricle (LV) compared to all other techniques.ConclusionsConsidering the complex anatomical relation between target volumes and organs at risk (OARs), IMPT can provide a dose advantage for organs located outside of the target area rather than within or surrounding the area. It is hoped that advances in proton therapy (PT) plan design will lead to further improvements in radiotherapy approaches and provide the best treatment choice for individual patients.https://www.frontiersin.org/articles/10.3389/fonc.2020.611514/fullproton radiotherapycardiac sparingwhole lung irradiationpediatric tumorphoton radiotherapy
spellingShingle Xue Sha
Jinghao Duan
Xiutong Lin
Jian Zhu
Jian Zhu
Ruohui Zhang
Tao Sun
Hui Wang
Xiangjuan Meng
Yong Yin
A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
Frontiers in Oncology
proton radiotherapy
cardiac sparing
whole lung irradiation
pediatric tumor
photon radiotherapy
title A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
title_full A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
title_fullStr A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
title_full_unstemmed A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
title_short A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients
title_sort new proton therapy solution provides superior cardiac sparing compared with photon therapy in whole lung irradiation for pediatric tumor patients
topic proton radiotherapy
cardiac sparing
whole lung irradiation
pediatric tumor
photon radiotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2020.611514/full
work_keys_str_mv AT xuesha anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jinghaoduan anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT xiutonglin anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jianzhu anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jianzhu anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT ruohuizhang anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT taosun anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT huiwang anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT xiangjuanmeng anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT yongyin anewprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT xuesha newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jinghaoduan newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT xiutonglin newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jianzhu newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT jianzhu newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT ruohuizhang newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT taosun newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT huiwang newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT xiangjuanmeng newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients
AT yongyin newprotontherapysolutionprovidessuperiorcardiacsparingcomparedwithphotontherapyinwholelungirradiationforpediatrictumorpatients